DIVERSE BIOTECH, INC.
MIAMI, FL · Founded 2017 · CIK 0001744231 · Biotech · Private
Novel drug conjugate platform combining synthetic cannabinoids with targeted cancer therapeutics
diversebiotech.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $669K
- 3 Form D · Mar 2023
- 43 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 32
- 4 granted · 28 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $669,000 | |
| Private capital raised | Form D · SEC | $8,997,723 | |
| Private capital raised | Form D · SEC | $950,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1610 | CEL-SCI CORPORATION | — | $1.1M |
| 1611 | CELL ORIGINS, LLC | — | — |
| 1612 | GATC HEALTH CORP | — | $981K |
| 1613 | DIVERSE BIOTECH, INC. | — | $669K |
| 1614 | XORTX Therapeutics Inc. | — | $505K |
| 1615 | Stratum Biosciences Inc. | — | $100K |
| 1616 | Generate Biomedicines | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- PHILIP ARLENDirector
- Phyllis FenneyDirector
- WILLIAM FISHERDirector · Executive Officer · Promoter
- Phillip HaretosDirector
- JOHN PATRICKDirector
- BEAUDON SPAULDINGDirector · Executive Officer · Promoter
- STELLA VNOOKDirector · Executive Officer · Promoter
Patents
- Conjugate Moleculesapplication
- Platinum Complex Anti-Neoplastic Agents Comprising a Cannabinoid Ligandgranted
- Beta-Lactam-Cannabinoid Conjugate Moleculesapplication
- Beta-Lactam-Cannabinoid Conjugate Moleculesgranted
- Conjugate Moleculesgranted
- Conjugate Moleculesgranted
- Novel Cannabinoids Formulations and Their Use for the Treatment of Acute Flaccid Myelitisapplication
- Cannabinoid Conjugate Moleculesapplication
- Cannabinoid Conjugate Moleculesapplication
- Platinum Complex Anti-neoplastic Agents Comprising A Cannabinoid Ligandapplication
- Platinum Complex Anti-neoplastic Agents Comprising A Cannabinoid Ligandapplication
- Cannabinoid Conjugate Moleculesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.